Medical Cannabis Products: How Much Really Gets There-
Analyst Research Laboratories? A Tentamus Company, offers pre-clinical&clinical studies
(PresseBox) - More and more companies and entrepreneurs operating in the field of Cannabis realize that while the market for ?flowers? and ?extracts? is significant (and likely to grow), the true ?holy grail? lies in the area of cannabis-based therapies.
Among the many questions faced by any company developing a new drug, probably the most complicated are those related to the behavior of their drug in the human body. This is the field of ADME: Absorption, Distribution, Metabolism and Excretion, or, in other words, ?How much really gets there?? and where is actually ?There??
One of the tools for obtaining information related to the ADME behavior of the drug, is to determine the levels of compounds of interest in various biological tissues and fluids ? i.e., Bioanalytics. In pre-clinical (animal) studies, this can include the analyses of plasma, urine, feces, skin, internal organs and brain. Clinical (human) studies usually include plasma, urine and feces. One of the greatest challenges of determining the levels of cannabinoids in the body, is the highly sensitive detection levels required.
Analyst Research Laboratories, with its more than 2 decades of experience in the Pharmaceutical, Bioanalytical and Analytical arena, is employing this vast experience to the area of Medical Cannabis.
With in-house validated Bioanalytical and Analytical methods for a variety of cannabinoids, species and tissues, Analyst is routinely supporting its customers from Israel and abroad in their Pre-Clinical and Clinical studies.
If you are developing a new formulation or product, planning a pre-clinical or clinical trial, we will be more than happy to discuss your needs and see if we can help you.
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrochemicals, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 50 locations worldwide. More than 2,500 highly-trained staff members work in over 1 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food&feed, pharmaceuticals&medical, agrochemicals, cosmetics, agriculture&environment and nutraceutical&supplements). Tentamus Group is represented in over 50 locations worldwide. More than 2,500 highly-trained staff members work in over 1 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
Datum: 24.01.2019 - 04:14 Uhr
Sprache: Deutsch
News-ID 1546049
Anzahl Zeichen: 6811
contact information:
Contact person:
Town:
Ness Ziona, Israel
Phone:
Kategorie:
Energy & Utilities
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 416 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Medical Cannabis Products: How Much Really Gets There-
"
steht unter der journalistisch-redaktionellen Verantwortung von
Tentamus Group GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
